Sunday, June 14, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 249 of 1,261
  1. US 11401461

    Zirconia sintered body containing fluorescent agent

    KURARAY NORITAKE DENTAL INC. · Granted Aug 2, 2022 · Expires Jul 28, 2042

    granted
  2. US 11401317

    Human-CD123-targeting chimeric receptor ligand and application thereof

    Nanjing Legend Biotech Co., Ltd · Granted Aug 2, 2022 · Expires Jul 28, 2042

    granted
  3. US 11401314

    T-cell modulatory multimeric polypeptides and methods of use thereof

    Cue Biopharma, Inc. · Granted Aug 2, 2022 · Expires Jul 28, 2042

    granted
  4. US 11401306

    HPV16 non HLA-restricted t-cell vaccines, compositions and methods of use thereof

    PDS Biotechnology Corporation · Granted Aug 2, 2022 · Expires Jul 28, 2042

    granted
  5. US 11401320

    QTY FC fusion receptor proteins

    Avalon GloboCare Corp. · Granted Aug 2, 2022 · Expires Jul 28, 2042

    granted
  6. US 11401267

    Substituted benzyl-triazole compounds for Cbl-b inhibition, and further uses thereof

    NURIX THERAPEUTICS, INC. · Granted Aug 2, 2022 · Expires Jul 28, 2042

    granted
  7. US 11401256

    Dihydroquinolinones for medical treatment

    C4 THERAPEUTICS, INC. · Granted Aug 2, 2022 · Expires Jul 28, 2042

    granted
  8. US 11400284

    Method of transcutaneous electrical spinal cord stimulation for facilitation of locomotion

    The Regents of the University of California · Granted Aug 2, 2022 · Expires Jul 28, 2042

    granted
  9. US 11400161

    Method of conjugating oligomeric compounds

    Ionis Pharmaceuticals, Inc. · Granted Aug 2, 2022 · Expires Jul 28, 2042

    granted
  10. US 11400164

    Immunoconjugates targeting HER2

    Bolt Biotherapeutics, Inc. · Granted Aug 2, 2022 · Expires Jul 28, 2042

    granted
  11. US 11400158

    Biodegradable lipids for the delivery of active agents

    Alnylam Pharmaceuticals, Inc. · Granted Aug 2, 2022 · Expires Jul 28, 2042

    granted
  12. US 11400108

    Cyclic dinucleotides as agonists of stimulator of interferon gene dependent signalling

    The Board of Regents of the University of Texas System · Granted Aug 2, 2022 · Expires Jul 28, 2042

    granted
  13. US 11400104

    Skeletal removal of bisphosphonates

    The Regents of the University of California · Granted Aug 2, 2022 · Expires Jul 28, 2042

    granted
  14. US 11400098

    Method of treating microbial infections

    The Regents of the University of California · Granted Aug 2, 2022 · Expires Jul 28, 2042

    granted
  15. US 11400072

    Methods for the treatment of nonalcoholic fatty liver disease and/or lipodystrophy

    Coherus BioSciences, Inc. · Granted Aug 2, 2022 · Expires Jul 28, 2042

    granted
  16. US 11400066

    Methods of treatment of inflammation related conditions using pluripotent anti-inflammatory and metabolic modulators

    INSTITUT PASTEUR DE MONTEVIDEO · Granted Aug 2, 2022 · Expires Jul 28, 2042

    granted
  17. US 11400063

    Early administration of low-dose colchicine after myocardial infarction

    INSTITUT DE CARDIOLOGIE DE MONTREAL · Granted Aug 2, 2022 · Expires Jul 28, 2042

    granted
  18. US 11400052

    Alcohol-resistant drug formulations

    Jazz Pharmaceuticals Ireland Limited · Granted Aug 2, 2022 · Expires Jul 28, 2042

    granted
  19. US 11399540

    Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto

    CORTEVA AGRISCIENCE LLC · Granted Aug 2, 2022 · Expires Jul 28, 2042

    granted
  20. WO 2022158991

    TRAITEMENT DE LA DOULEUR ASSOCIÉE À LA MALADIE DE PARKINSON AVEC DE L'OPICAPONE EN COMBINAISON AVEC LA LÉVODOPA

    BIAL PORTELA & CA SA [PT] · Granted Jul 28, 2022 · Expires Jul 23, 2042

    granted
  21. IT 202100001169

    GEL MUCOADESIVO BUCCALE CONTENENTE PROBIOTICI PER USO NELLA PREVENZIONE E NEL TRATTAMENTO DELLE MALATTIE PARODONTALI.

    ALFASIGMA SPA [IT] · Granted Jul 27, 2022 · Expires Jul 22, 2042

    granted
  22. EP 4031157

    BAKTERIENSTÄMME, IHRE ZUSAMMENSETZUNGEN UND IHRE VERWENDUNG ZUR BEHANDLUNG GASTROINTESTINALER ERKRANKUNGEN

    SOFAR SPA [IT] · Granted Jul 27, 2022 · Expires Jul 22, 2042

    granted
  23. US 11395855

    Exon skipping oligomer conjugates for muscular dystrophy

    Sarepta Therapeutics, Inc. · Granted Jul 26, 2022 · Expires Jul 21, 2042

    granted
  24. US 11396530

    Bicyclic peptide ligands and uses thereof

    BicycleTx Limited · Granted Jul 26, 2022 · Expires Jul 21, 2042

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.